A Pharmacokinetic Study of an Experimental Paracetamol Formulation

GlaxoSmithKline (GSK)

Status and phase: Completed; Phase 1

Conditions: Headache, Tension-Type

Treatments: Drug: Paracetamol marketed formulation; Drug: Experimental paracetamol

Study type: Interventional

Funder types: Industry

Identifiers

NCT01476176

A2260665

Details and patient eligibility

About

This PK study is designed to show bioequivalence between the study treatments.

Enrollment: 30 patients

Sex: All

Ages: 18 to 55 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy volunteer

Exclusion criteria

Trial design

30 participants in 2 patient groups

Experimental paracetamol formulation

Experimental group

Description:

experimental formulation

Treatment:

Drug: Experimental paracetamol

paracetamol marketed formulation

Active Comparator group

Description:

Paracetamol marketed formulation

Treatment:

Drug: Paracetamol marketed formulation